Acute profound thrombocytopenia after use of eptifibatide for coronary stenting
- 30 December 2002
- journal article
- case report
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 58 (1) , 73-75
- https://doi.org/10.1002/ccd.10390
Abstract
This is a case report of a patient who developed profound thrombocytopenia during treatment with eptifibatide after PCI of the mid right coronary artery.Keywords
This publication has 10 references indexed in Scilit:
- Association of eptifibatide and acute profound thrombocytopeniaThe American Journal of Cardiology, 2001
- Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial InfarctionNew England Journal of Medicine, 2001
- Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trialThe Lancet, 2000
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularizationJournal of the American College of Cardiology, 1998
- Drug-Induced Thrombocytopenia: Is it a Serious Concern for Glycoprotein IIb/IIIa Receptor Inhibitors?Journal of Thrombosis and Thrombolysis, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-IIThe Lancet, 1997
- Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusionThe American Journal of Cardiology, 1996
- Heparin-Induced Thrombocytopenia and ThrombosisNew England Journal of Medicine, 1995